Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Açık Bilim Politikası
Açık Bilim Politikası
Frequently Asked Questions
Frequently Asked Questions
Browse
Browse
By Issue Date
By Issue Date
Authors
Authors
Titles
Titles
Subjects
Subjects
Communities & Collections
Communities & Collections
Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
Download
index.pdf
Date
2014-07-01
Author
Gungor, Bilgi
Yagci, Fuat Cem
GÜRSEL, İHSAN
Gürsel, Mayda
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
0
views
0
downloads
Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple strategy to convert a Toll-like receptor 9 (TLR9) agonist devoid of interferon alpha (IFN alpha) stimulating activity into a robust Type I interferon inducer with potent vaccine adjuvant activity.
Subject Keywords
CpG ODN
,
Type I interferon
,
Vaccine adjuvant
URI
https://hdl.handle.net/11511/42937
Journal
ONCOIMMUNOLOGY
DOI
https://doi.org/10.4161/21624011.2014.950166
Collections
Department of Biology, Article